• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过胸腔积液诊断出具有小细胞癌成分的肺癌以及通过肿瘤诊断出具有鳞状细胞癌成分的肺癌。

Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor.

作者信息

Zaizen Yoshiaki, Tokito Takaaki, Masuda Ken, Azuma Koichi, Naito Yoshiki, Tsuneyoshi Shingo, Sakazaki Yuki, Matsuo Norikazu, Ishii Hidenobu, Yamada Kazuhiko, Akiba Jun, Hoshino Tomoaki

机构信息

Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Japan.

Department of Diagnostic Pathology, Kurume University School of Medicine, Japan.

出版信息

Intern Med. 2018 Dec 1;57(23):3419-3422. doi: 10.2169/internalmedicine.1200-18. Epub 2018 Jul 6.

DOI:10.2169/internalmedicine.1200-18
PMID:29984774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6306528/
Abstract

There have been few reports on the accuracy of the diagnosis of small-cell carcinoma based on a cytological examination of malignant pleural effusion, so whether or not such a diagnosis is possible using this approach alone remains unclear. We herein report a 76-year-old Japanese man in whom small-cell carcinoma was diagnosed cytopathologically from pleural effusion and squamous cell carcinoma was diagnosed histopathologically from a transbronchial biopsy. Tumor shrinkage was achieved by treatment with docetaxel, but the efficacy of carboplatin plus etoposide was inadequate. If small-cell carcinoma is detected on the basis of pleural fluid cytopathology alone, it is extremely important to perform a histopathological examination to rule out the possibility of other malignancies.

摘要

关于基于恶性胸腔积液的细胞学检查诊断小细胞癌的准确性的报道较少,因此仅用这种方法能否做出诊断仍不明确。我们在此报告一名76岁的日本男性,其通过胸腔积液的细胞病理学诊断为小细胞癌,通过经支气管活检的组织病理学诊断为鳞状细胞癌。多西他赛治疗实现了肿瘤缩小,但卡铂加依托泊苷的疗效不佳。如果仅基于胸水细胞病理学检测到小细胞癌,进行组织病理学检查以排除其他恶性肿瘤的可能性极其重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c435/6306528/d455f989fb47/1349-7235-57-3419-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c435/6306528/edb81c37a838/1349-7235-57-3419-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c435/6306528/a53770cac5ee/1349-7235-57-3419-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c435/6306528/d455f989fb47/1349-7235-57-3419-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c435/6306528/edb81c37a838/1349-7235-57-3419-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c435/6306528/a53770cac5ee/1349-7235-57-3419-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c435/6306528/d455f989fb47/1349-7235-57-3419-g003.jpg

相似文献

1
Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor.通过胸腔积液诊断出具有小细胞癌成分的肺癌以及通过肿瘤诊断出具有鳞状细胞癌成分的肺癌。
Intern Med. 2018 Dec 1;57(23):3419-3422. doi: 10.2169/internalmedicine.1200-18. Epub 2018 Jul 6.
2
Histologic transformation of lung cancer during pembrolizumab therapy: A case report.帕博利珠单抗治疗期间肺癌的组织学转化:一例报告。
Thorac Cancer. 2020 Mar;11(3):793-796. doi: 10.1111/1759-7714.13312. Epub 2020 Jan 16.
3
[A case of lung cancer in an elderly patient with malignant pleural effusion and pneumothorax treated with carboplatin, pemetrexed, and bevacizumab].[1例老年肺癌患者合并恶性胸腔积液和气胸接受卡铂、培美曲塞和贝伐单抗治疗的病例]
Gan To Kagaku Ryoho. 2014 Oct;41(10):1237-40.
4
Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.血浆和胸腔积液中的血管内皮生长因子是贝伐单抗联合卡铂-紫杉醇治疗非小细胞肺癌伴恶性胸腔积液后预后的生物标志物。
Anticancer Res. 2016 Jun;36(6):2939-44.
5
[A case of lung cancer showing marked reduction of pleural effusion by bevacizumab in combination with carboplatin and paclitaxel].1例肺癌患者使用贝伐单抗联合卡铂和紫杉醇后胸腔积液显著减少
Gan To Kagaku Ryoho. 2011 Nov;38(11):1877-9.
6
Malignant pleural effusion from a case of squamous-cell carcinoma of the oral cavity: Cytological detection of a rare outcome.口腔鳞状细胞癌并发恶性胸腔积液:一种罕见结果的细胞学检测。
Diagn Cytopathol. 2023 May;51(5):E161-E163. doi: 10.1002/dc.25110. Epub 2023 Jan 31.
7
Malignant mesothelioma mimicking squamous carcinoma in a pleural fluid aspirate.胸腔积液穿刺液中酷似鳞状细胞癌的恶性间皮瘤。
Cytopathology. 2001 Feb;12(1):54-6. doi: 10.1046/j.1365-2303.2001.00284.x.
8
A Case of Massive Pleural Effusion: Pleurodesis by Bleomycin.一例大量胸腔积液:博来霉素胸膜固定术
Mymensingh Med J. 2016 Apr;25(2):374-8.
9
Optimizing the Approach to Patients With Pleural Effusion and Radiologic Findings Suspect for Cancer.优化对胸腔积液且影像学表现疑似癌症患者的诊疗方法。
J Bronchology Interv Pulmonol. 2019 Apr;26(2):114-118. doi: 10.1097/LBR.0000000000000537.
10
Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature.贝伐单抗治疗难治性雷莫西尤单抗的非小细胞肺癌恶性胸腔积液:一例报告及文献复习
Oncotarget. 2017 Jul 18;8(29):48521-48524. doi: 10.18632/oncotarget.17952.

本文引用的文献

1
The value of cytological diagnosis of small cell lung carcinoma.小细胞肺癌细胞学诊断的价值
Pneumonol Alergol Pol. 2010;78(3):203-10.
2
Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence.不同诊断方式对疑似肺癌的诊断性能特征:已发表证据综述
Chest. 2003 Jan;123(1 Suppl):115S-128S. doi: 10.1378/chest.123.1_suppl.115s.
3
Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study.小细胞肺癌所致恶性胸腔积液:一项细胞学和免疫细胞化学研究
Diagn Cytopathol. 2001 Dec;25(6):356-60. doi: 10.1002/dc.10011.
4
Malignancy metastatic to the pleura.转移至胸膜的恶性肿瘤。
Clin Chest Med. 1998 Jun;19(2):351-61. doi: 10.1016/s0272-5231(05)70082-4.